Peptide brands can advertise on Google, but it is one of the easiest categories to get wrong. Disapproved ads, “eligible (limited)” campaigns and suspended accounts usually come down to a handful of avoidable mistakes. We run Google, Microsoft (Bing), Meta and TikTok ads for research peptide brands, and this guide explains what Google actually checks, why accounts get banned, and how to build Search and Shopping campaigns that stay live.
This article is general information, not legal advice. Google’s policies change and approval always depends on your specific products, so check the current policy before you launch.
The short answer
Yes, you can run Google Ads for a research peptide store, if the whole funnel is built around the rules instead of around ways to dodge them. That means:
- Research-only positioning everywhere: ads, keywords, product pages, landing pages and your product feed.
- No human-use, dosing, injection or disease claims anywhere a reviewer or customer can see.
- Keywords built around your brand, your category and research-supplier searches, not restricted product names.
- A transparent business: real company details, contact information, policies and third-party testing.
- No cloaking, coded names or misspellings, and no new accounts to get around a suspension.
What Google’s policy actually says
Peptides fall under Google’s Healthcare and medicines policy. Its section on unapproved substances says Google does not allow the promotion of certain products “regardless of any claims of legality”. That covers everything on its list of unapproved pharmaceuticals and supplements, products that imply they are as effective as prescription drugs, and products marketed as safe or effective for preventing, curing or treating a disease without government approval.
Three details catch most brands out:
- The list is not exhaustive. Most research peptides are not named on it, but that does not mean they are approved. Google judges the product and how you present it.
- Google reviews the whole funnel. Ads, keywords, images, your product feed and your landing pages are all checked. A perfectly worded ad that sends people to a page with dosing instructions will still be disapproved.
- Enforcement is automated first. Most decisions are made by systems scanning text and pages, so a single risky word on a product page can trigger a disapproval long after launch.
Why peptide accounts get suspended
Disapprovals are warnings. Suspensions usually follow repeated or serious violations, and some violations suspend an account immediately. The most common triggers we see:
- Keywords and ad text built around restricted product names.
- Landing or product pages with dosing charts, injection guides, “for weight loss” style benefits or before-and-after claims.
- Customer reviews on product pages that describe personal use. Google reads those as your claims.
- Cloaking: showing reviewers one page and customers another. Under Google’s Circumventing systems policy, accounts are suspended “upon detection and without prior warning”.
- Disguising products with coded names or deliberate misspellings. Reviewers see through it, and it signals that the business knows the product breaks the rules.
- Opening a new account, or a new site showing the same disapproved ads, after a suspension. Google treats that as suspension evasion and it usually ends with every linked account banned.
We review your site, product pages and keyword plan against Google’s policies and tell you exactly what to change before you launch. It is free.
Book a free strategy call →How to build peptide campaigns that stay approved
1. Start with a clean, transparent account
Run campaigns in an account owned by your business, with accurate business details, completed advertiser verification and consistent billing. Accounts linked to past violations are reviewed more strictly, so a clean history matters more than in almost any other category.
2. Fix the website before you spend
Most suspensions start on the website, not in the ad. Before launch, check every product page, category page, blog post and review for human-use, dosing or disease language. Add clear research-use disclaimers, certificates of analysis, your business address, contact details, and shipping, returns and privacy policies.
3. Choose keywords carefully
Build Search campaigns around your brand, your category and research-supplier searches rather than restricted product names. Review the search terms report every week and add negative keywords so ads do not drift into dosing, injection or treatment searches.
4. Use dedicated, ads-compliant landing pages
Send ad traffic to pages built for the campaign rather than to a busy homepage. Show your business name, contact details, policies and third-party testing, keep the message consistent with the ad, and make sure the page loads fast and is easy to navigate. Reviewers and customers must see exactly the same page.
5. Treat Shopping as its own project
Google Shopping runs through Merchant Center, which has its own reviews and its own suspensions (most often for “misrepresentation”). Product titles, descriptions and images in your feed must follow the same research-only rules as your site, and some products are best kept out of Shopping entirely. We cover this in detail in our Merchant Center guide for peptide and supplement stores.
6. Review before launch, then monitor daily
Check every ad, extension and landing page against the policy before it goes live, then watch policy status daily for the first weeks. If something is disapproved, fix the cause first and only then request a review. Repeatedly appealing without changes is a fast way to lose the ability to appeal at all.
What a realistic first 90 days looks like
- Weeks 1–2: setup and review. Site fixes, conversion tracking (GA4 and Google Ads), Merchant Center and feed setup, campaign build and policy review.
- Weeks 3–6: learning. Campaigns gather data. Expect some disapprovals to fix and keywords to prune. This is normal in a restricted category.
- Weeks 7–12: optimisation. Budget moves to the campaigns, products and searches that convert. Bidding can shift towards return-on-ad-spend targets once there is enough conversion data.
If you are deciding how much to start with, see our guide to Google Ads budgets for peptide brands.
If your account is suspended
Do not open a new account. Find the policy named in the suspension notice, fix the cause across your ads and website, then submit one clear appeal from the suspended account. Our step-by-step guide on what to do when a Google Ads account is suspended walks through it.
Do not rely on Google alone
The strongest peptide brands spread their spend. Microsoft (Bing) Ads adds search reach, often at a lower cost per click. Meta and TikTok can work for awareness and retargeting with compliant creative, and SEO, email and SMS build traffic no platform can switch off.
A quick compliance checklist
- No human-use, dosing, injection or disease claims in ads, on landing pages, in reviews or in your product feed.
- No keywords or ad text built around restricted product names.
- No cloaking, coded names or misspellings to get around review.
- Clear business information, contact details and policies on every landing page.
- Certificates of analysis and research-use disclaimers on product pages.
- Search terms, policy status and disapprovals checked every week.
- Your accounts, your data. Campaigns run in your own Google Ads and Merchant Center accounts. You keep admin access and full history, even if you stop working with us.
- No tricks. No cloaking, coded product names or deliberate misspellings to get past review.
- Same page for everyone. Reviewers and customers see the same business, products and claims.
- We fix and appeal. If something is disapproved or suspended, we fix the cause and request a review. We never move you to a new account to get around a suspension.
The bottom line
Peptide brands can grow with Google Ads when campaigns are built around the rules instead of around ways to dodge them. Get the account, website, keywords and feed right, monitor closely, and paid search becomes a reliable growth channel instead of a gamble.
